Even after the metabolic syndrome patients were excluded from the control group, serum irisin levels were still significantly higher in the NAFLD group than the control group (63.4±32.6 vs. 43.7±30.3, p<0.001). Here, FNDC5 is linked to metabolic dysfunction-associated steatotic liver disease.